14th European Meeting on HIV & Hepatitis 2016

25.05.16 - 27.05.16
Roma Eventi – Fontana di Trevi Conference Centre
Piazza della Pilotta, 4. 


This meeting was started 15 years ago with the objective to provide clinical virologists and other infectious diseases treating specialists involved in both research and clinical practice with the opportunity to share data and discuss their clinical application. The focus of the workshop at the time was specifically on HIV antiretroviral drug resistance, which was the main challenge facing the clinician a decade ago. Hence the original name as the European Drug Resistance workshop.


Over the years the challenges facing European clinicians treating HIV patients expanded. As resistance was better understood and managed, broader treatment issues (adherence, toxicity, etc.) were added to the workshop. Similarly, as better treatments for HCV became available, many of them were required to treat viral Hepatitis as well. Therefore the workshop (and its name) were expended to keep pace with the needs of the European clinicians – The European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance. Although resistance is still an important feature of the meeting, the other key topics in treatment strategies are addressed – similarly although HIV remains very much a key component – treatment of Hepatitis infection is also included.


Again in 2016: including the International Workshop on Hepatitis C Resistance and New Compounds, on Thursday 27 May 2016  at 14.00.


Find attached the preliminary program.

Download document (application/pdf)

Publications and presentations related to the conference

  • 25/05/2016 - Roadblocks to implementation

    Session 4: Implementation of PrEP in Europe

    16.00 Roadblocks to implementation - Pep Coll, MD, PhD, IrsiCaixa Foundation, Barcelona, Spain

    16.30 Community perspective - Rebekah Webb, MA, EATG,...

  • 27/05/2016 - Diagnostic Assays

    Session 7: HIV Cure

    11.00 Boston Project - Timothy Henrich, MD, UCSF, USA

    11.30 Diagnostic Assays - Javier Martinez Picado, PhD, Irsi Caixa Foundation, Barcelona, Spain